Publications by authors named "Julie Roques"

Claim this Profile
P
Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers.
Abdessamad El Kaoutari, Nicolas A Fraunhoffer, Stéphane Audebert, Luc Camoin, Yolande Berthois, Julie Roques

EBioMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity.
Nicolas Alejandro Fraunhoffer, Analía Meilerman Abuelafia, Brice Chanez, Martin Bigonnet, Odile Gayet, Julie Roques

Cancer Commun (Lond)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction.
Nicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques

NPJ Precis Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis.
Yousra Mohamed Abd-El-Halim, Abdessamad El Kaoutari, Françoise Silvy, Marion Rubis, Martin Bigonnet, Julie Roques

EBioMedicine· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-α induces endothelial-mesenchymal transition promoting stromal development of pancreatic adenocarcinoma.
Marjorie Adjuto-Saccone, Philippe Soubeyran, Julie Garcia, Stéphane Audebert, Luc Camoin, Julie Roques

Cell Death Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models.
Owen Hoare, Nicolas Fraunhoffer, Abdessamad Elkaoutari, Odile Gayet, Martin Bigonnet, Julie Roques

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance.
Abdessamad El Kaoutari, Nicolas A Fraunhoffer, Owen Hoare, Carlos Teyssedou, Philippe Soubeyran, Julie Roques

EBioMedicine· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib.
Nicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype.
Natalia Juiz, Abdessamad Elkaoutari, Martin Bigonnet, Odile Gayet, Julie Roques

FASEB J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer.
Rémy Nicolle, Yuna Blum, Pauline Duconseil, Charles Vanbrugghe, Nicolas Brandone, Julie Roques

EBioMedicine· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PML hyposumoylation is responsible for the resistance of pancreatic cancer.
Mirna Swayden, George Alzeeb, Rawand Masoud, Yolande Berthois, Stéphane Audebert, Julie Roques

FASEB J· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi).
Benjamin Bian, Natalia Anahi Juiz, Odile Gayet, Martin Bigonnet, Nicolas Brandone, Julie Roques

Front Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.
Christian Bressy, Sophie Lac, Jérémy Nigri, Julie Leca, Julie Roques

Cancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.
Jérémy Nigri, Meritxell Gironella, Christian Bressy, Elena Vila-Navarro, Julie Roques

Cell Mol Life Sci· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.
Rémy Nicolle, Yuna Blum, Laetitia Marisa, Celine Loncle, Odile Gayet, Julie Roques

Cell Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions.
Orianne Olivares, Jared R Mayers, Victoire Gouirand, Margaret E Torrence, Tristan Gicquel, Julie Roques

Nat Commun· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
Julie Leca, Sébastien Martinez, Sophie Lac, Jérémy Nigri, Véronique Secq, Julie Roques

J Clin Invest· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.
Fabienne Guillaumond, Ghislain Bidaut, Mehdi Ouaissi, Stéphane Servais, Victoire Gouirand, Julie Roques

Proc Natl Acad Sci U S A· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis